Two healthcare data companies joined forces on Thursday to address historical diversity and inclusion challenges in clinical trials. Atropos Health, a Palo Alto-based company that delivers clinical data to physicians at the point of…
Continue Reading
Leader in Unlocking Real-World Data for Healthcare Moves to Address the Global Evidence Gap in Markets Plagued by Tight Data Restrictions and a Lack of Clinical Trial Diversity
Atropos Health, a pioneer in evidence-based healthcare…
What You Should Know:
Atropos Health, a pioneer in evidence-based healthcare known for its Green Button Clinical Informatics Consult Service, today announced that it has completed strategic financing from Presidio Ventures, the venture arm of Sumitomo…
Continue Reading
The American Society for Radiation Oncology (ASTRO) strongly supports the nomination of Dr. Monica Bertagnolli as director of the National Institutes of Health (NIH). ASTRO commends her advocacy for research, innovation, and equity, particularly…
Continue Reading
Almost three-quarters of all clinical trials are run by the same 5% of academic sites, according to Inato CEO Kourosh Davarpanah.
“This lack of patient access causes trial delays and costs to skyrocket, ultimately constraining…
What You Should Know:– H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced the availability of indication-level diversity insights in addition to institution, provider, and patient diversity data…
Continue Reading
As we dive right into 2023, medical affairs teams are at a turning point.
MSLs are no longer wasting valuable time waiting in line within the halls of ivory towers, trying to get face-time or…
Over the past few years, it’s become a business truism that “every company is a data company.” We’ve seen the use of data analytics help business and IT leaders to arrive at new insights…
Continue Reading
